Navigating the balance: Risk and relief in opioid prescribing for patients with cancer
Cancer · 2025-10 · 131 (19)
DOI: 10.1002/cncr.70068 ↗Kurz gefasst
Editorial in der Zeitschrift Cancer, online erschienen am 22.09.2025. Verfasst von Romesh P Nalliah und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan School of Dentistry, Ann Arbor, Michigan, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Opioid prescribing for cancer pain is declining, but patients who have pain still receive them at similar rates. The authors call for balanced, evidence‐based opioid use to ensure both safety and effective pain relief.
Autor:innen und Institutionen
- University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
- University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
- Department of Anesthesiology, Michigan Medicine, Ann Arbor, Michigan, USA.
- Opioid Research Institute, Office for the Vice President for Research, University of Michigan, Ann Arbor, Michigan, USA.
- Overdose Prevention Engagement Network, Institute for Healthcare Policy and Innovation, Michigan Medicine, Ann Arbor, Michigan, USA.
ORCID-Profile: Romesh P Nalliah
Zitieren
APA
Nalliah, R. P., & Brummett, C. M. (2025). Navigating the balance: Risk and relief in opioid prescribing for patients with cancer. Cancer, 131(19). https://doi.org/10.1002/cncr.70068
Vancouver
Nalliah RP, Brummett CM. Navigating the balance: Risk and relief in opioid prescribing for patients with cancer. Cancer. 2025;131(19). doi:10.1002/cncr.70068
BibTeX
@article{Nalliah2025,
author = {Nalliah, Romesh P and Brummett, Chad M},
title = {Navigating the balance: Risk and relief in opioid prescribing for patients with cancer},
journal = {Cancer},
year = {2025},
volume = {131},
number = {19},
doi = {10.1002/cncr.70068}
}
EUVIMED